Article Text

Download PDFPDF

Protocol for the trismus trial—therabite versus wooden spatula in the amelioration of trismus in patients with head and neck cancer: randomised pilot study
  1. Rana Lee1,
  2. Alex Molassiotis2,
  3. Simon N Rogers3,
  4. Rhiannon Tudor Edwards4,
  5. David Ryder5,
  6. Nick Slevin1
  1. 1 Department of Clinical Oncology, The Christie NHS Foundation Trust Hospital, Manchester, UK
  2. 2 The School of Nursing, Hong Kong Polytechnic University, China, Hong Kong
  3. 3 Evidence-Based Practice Research Centre (EPRC), Edge Hill University, Liverpool, UK
  4. 4 Centre for Health Economics & Medicines Evaluation, Bangor University, Bangor, UK
  5. 5 Clinical Trials Unit, The Christie NHS Foundation Trust Hospital, Manchester, UK
  1. Correspondence to Ms Rana Lee; rana.lee{at}christie.nhs.uk

Abstract

Introduction Patients can develop trismus from their head and neck cancer or as a result of treatment. Trismus affects the jaw muscles and makes mouth opening difficult. To potentially combat trismus, patients could undertake proactive jaw stretching exercises prior to, during and after radiotherapy, although currently these are not the standard of care.

Methods and analysis This is a randomised, open-label, controlled, two-centre feasibility study, to assess the objective and subjective effectiveness and cost-effectiveness of therabite use compared with wooden spatula in ameliorating trismus in patients treated for stage 3 and 4 oral and oropharyngeal cancer, managed either by primary surgery followed by (chemo)radiotherapy or primary (chemo)radiotherapy. The principal objective assessment is measurement of maximum jaw opening. Assessments in all cases will be performed preradiotherapy and again at 3 and 6 months postintervention.

Secondary aims of the study will be (1) to assess whether therabite or the wooden spatula intervention improves patients’ quality of life, (2) reduce the level of post-treatment clinical management/healthcare use and (3) a nested qualitative study will explore the experience of the patient taking part in the intervention; data will be transcribed verbatim and analysis will be based on content analysis methods using the interview questions as the framework for examination.

Ethics and dissemination North West Greater Manchester granted ethical approval (REC Reference 11/NW/0744). Good Clinical Practice and the Declaration of Helsinki have been adhered to. The results will be presented internationally and submitted to a peer-reviewed journal. Head and neck cancer charities and information websites will also be approached.

Trial registration number NCT01733797.

  • adult radiotherapy
  • clinical Trials
  • oral medicine
  • health economics

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors NS and RL conceived the study design. NS is the grant holder and CI of the study. AM, SNR and RTE are coinvestigators. DR provided statistical expertise in clinical trial design. RTE provide the Health Economics input entirely. All the authors approved the protocol.

  • Funding This research is funded by the National Institute for Health Research (Research for Patient Benefit) NIHR (RfPB). Grant reference number PB_PG_0610_22317.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Ethics approval North West Greater Manchester which granted ethical approval (REC Reference (11 /NW/0744). ‘The Christie NHS Foundation Trust Hospital acknowledges the support of the National Institute of Health Research Clinical Research Network’ (NIHR CRN: Trismus RfPB trial (portfolio ID 13415).

  • Provenance and peer review Not commissioned; peer reviewed for ethical and funding approval prior to submission.